"10.1371_journal.pone.0072612","plos one","2013-08-15T00:00:00Z","Zhaohui Li; He Sun; Jianbin Zhang; Haijiao Zhang; Fanyu Meng; Zhanfeng Cui","Institute of Biomedical Engineering, University of Oxford, Oxford, United Kingdom; Tianjin Weikai Bioeng Ltd, Tianjin, China","Conceived and designed the experiments: ZL ZC. Performed the experiments: HS JZ HZ FM. Analyzed the data: ZL ZC HS. Wrote the manuscript: ZL ZC.","Zyoxel Limited, an Oxford University spin-off company, was established in 2009 based on the TissueFlex technology developed by Zhanfeng Cui and his group at Oxford University. Zhanfeng Cui is a nonexecutive director of Zyoxel. Tianjin Weikai Bioeng Limited licensed Zyoxels TissueFlex technology and manufactures
TissueFlex in China. Zhanfeng Cui chairs the scientific advisory board of Tianjin Weikai, acting like a consultant. Tianjin Weikai Bioeng collaborates with Oxford University in research on cell culture and
drug testing methodology, and this paper is a direct result of such collaboration. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Zhaohui Li","ZL",6,TRUE,2,4,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
